Abstract
Poor antiretroviral therapy (ART) adherence rates (taking less than 95% of medications as pre-scribed) for HIV positive individuals are empirically proven to have negative outcomes (Azia et al., 2016) as well as increased risk of adverse clinical outcomes (Hinkin et al., 2007) and this is the main reason for treatment failure and development of virological resistance (Barfod et al., 2006). Maintaining high levels of adherence to antiretroviral therapy (ART) is a chal-lenge across settings and populations therefore understanding the relative importance of differ-ent barriers to adherence will help inform the targeting of different interventions and future research priorities(Shubber et al., 2016). According to (Nsimba et al., 2010), adherence is described as engagement and accurate participation of an informed patient in a plan of care. Addressing adherence issues is essential to avoid changing medications as it would be pointless to just change the regimens without attending to such issues (Ahmed et al., 2019)...
M.A. (Public Health)